GlobalFoundries Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 MALTA, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) — GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the second quarter ended June 30, 2025. Key Second Quarter Financial Highlights Revenue of $1.688 billion Gross margin of 24.2% and Non-IFRS gross margin(1) of […]

Ontario Media Advisory: MADD Canada and its Local Chapter MADD Windsor & Essex County to Unveil Memorial Garden in Honour of Victims and Survivors of Crashes Involving Alcohol and/or Drugs GlobeNewswire August 05, 2025 WINDSOR, Ontario, Aug. 05, 2025 (GLOBE NEWSWIRE) — MADD Canada and its local Chapter MADD Windsor & Essex County will host

Enviri Corporation Reports Second Quarter 2025 Results GlobeNewswire August 05, 2025 Second quarter revenues totaled $562 million Second quarter GAAP consolidated loss from continuing operations of $46 million Adjusted EBITDA in Q2 totaled $65 million 2025 Adjusted EBITDA now expected to be within a range of $290 million to $310 million and free cash flow

Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights GlobeNewswire August 05, 2025 – First patient dosed in combination trial of TNG462 and Revolution Medicines RAS(ON) inhibitors – – First patient dosed in Phase 1/2 trial with TNG456, a brain-penetrant MTA-cooperative PRMT5 inhibitor in development for glioblastoma – BOSTON, Aug. 05, 2025

Bitfarms Announces Partnership with T5 Data Centers to Advance HPC/AI Development at Panther Creek Campus GlobeNewswire August 05, 2025 TORONTO, Ontario and NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF) (the “Company”), a global energy and compute infrastructure company, today announced its partnership with T5 Data Centers, LLC (“T5”) to advance

Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update GlobeNewswire August 05, 2025 FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical synergistic benefit of FHD-909 in combination with pembrolizumab and KRAS

Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire August 05, 2025 SAN MATEO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in a fireside chat at the

Xtract One Chosen by Volusia County Schools to Advance School Safety Xtract One Gateway Deployment to Improve School Security Screenings with Non-intrusive Technology for the 2025-2026 School Year GlobeNewswire August 05, 2025 TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract

Iterum Therapeutics Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 –– Launch of ORLYNVAHTM Expected August 2025– –-Cash Runway into 2026– –Company to host conference call today at 8:30amET– DUBLIN and CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV

Forsys Announces Commencement of Expansion Drill Program at Namibplaas GlobeNewswire August 05, 2025 TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) Forsys is pleased to announce the commencement of a drill program comprising 64 drill holes at its Namibplaas uranium property (“Namibplaas” or